NEW YORK (GenomeWeb News) – Epigenetics tools firm EpiCypher today announced it has selected Tebu-bio as its distribution partner in Europe.

Tebu-bio will distribute Research Triangle Park, NC-based EpiCypher's epigenetics and chromatic biology research products. Tebu-bio is based in Le Perray, France and has offices in Belgium, Germany, Italy, the Netherlands, Denmark, Finland, Norway, Sweden, Portugal, Spain, and the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.